Losartan Potassium Tablet
Product Images NDC 70518-3282

11 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 70518-3282). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 01)

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 01)
Chemical structure diagram of Losartan Potassium, showing its molecular components and arrangement including the potassium ion.*
FDA Label Image

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 02)

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 02)
A line graph comparing the percentage of patients with a primary endpoint over study months for Atenolol and Losartan. The x-axis represents study months from 0 to 66, and the y-axis shows the percentage of patients up to 16%. Atenolol is shown with a dotted line, and Losartan with a solid line. The graph notes an adjusted risk reduction of 13% with a p-value of 0.021.*
FDA Label Image

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 03)

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 03)
A line graph comparing the percentage of patients with fatal or non-fatal stroke over months of a study between Atenolol (dotted line) and Losartan (solid line). The x-axis represents study months from 0 to 66, and the y-axis shows the percentage of patients from 0 to 8. The graph includes an annotation of an adjusted risk reduction of 25% with a p-value of 0.001.*
FDA Label Image

Primary Endpoint Events Within Demographic Subgroups (102f37d5 4ea7 430a A75f Dbb6533301d8 04)

Primary Endpoint Events Within Demographic Subgroups (102f37d5 4ea7 430a A75f Dbb6533301d8 04)
A forest plot comparing Losartan and Atenolol event rates for primary composite outcomes and stroke (fatal/non-fatal) across various patient subgroups, including age, gender, race, isolated systolic hypertension (ISH), diabetes, and history of cardiovascular disease (CVD). The plot shows hazard ratios with 95% confidence intervals, indicating which treatment is favored for each subgroup.*
FDA Label Image

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 05)

Image (102f37d5 4ea7 430a A75f Dbb6533301d8 05)
A line graph showing the percentage of patients with an event over 48 months comparing Losartan 50 mg tablets and placebo. The solid line represents Losartan and the dashed line represents placebo, with data indicating a 16.1% risk reduction (p=0.022) for Losartan compared to placebo.*
FDA Label Image

Image (38431fb6 7157 4be5 929a 0c65b7a29c55 343 1)

Image (38431fb6 7157 4be5 929a 0c65b7a29c55 343 1)
Losartan Potassium 50 mg oral tablet label from REMEDYREPACK INC. The label includes black text and graphics on a white background, with a distinct design element made of oval shapes arranged in a vertical and horizontal pattern. No additional text or information is visible.*
FDA Label Image

Image (38431fb6 7157 4be5 929a 0c65b7a29c55 366 1)

Image (38431fb6 7157 4be5 929a 0c65b7a29c55 366 1)
Losartan Potassium 50 mg oral tablets packaging directed by RemedyRepack Inc. The package prominently displays the product name and strength with a decorative design in black on a white background, reflecting the label for a prescription drug tablet.*
FDA Label Image

Mm1 (Losartan Potassium 50mg 70518 3282 00)

Mm1 (Losartan Potassium 50mg 70518 3282 00)
Losartan Potassium 50 mg tablet packaging label showing quantity of 60 tablets. The label includes the NDC number 70518-3282-00, and indicates the product is repackaged by RemedyRepack Inc. Additional storage and handling instructions are provided, including protection from light and temperature conditions.*
FDA Label Image

Mm2 (Losartan Potassium 50mg 70518 3282 01)

Mm2 (Losartan Potassium 50mg 70518 3282 01)
Losartan Potassium 50 mg tablets packaging label showing a quantity of 30 tablets. The label includes the product name, dosage strength, and mentions repackaging by RemedyRepack Inc. It also notes the original manufacturer Lupin Pharma, Baltimore, MD. Storage instructions specify keeping the medication out of reach of children and temperature recommendations.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Losartan Potassium 50 mg tablet packaging label showing a quantity of 60 tablets. The label includes the product name, strength, dosage form, and mentions Remedy Repack as the repackager with manufacturer Lupin Pharma in Baltimore, MD. Directions and storage instructions are present, along with NDC 70518-3282-00.*
FDA Label Image

Mm4 (Losartan Potassium 50mg 70518 3282 03)

Mm4 (Losartan Potassium 50mg 70518 3282 03)
Losartan Potassium 50 mg tablet packaging label from RemedyRepack Inc. The label indicates a quantity of 100 tablets with NDC 70518-3282-03. It includes storage instructions to protect from light and keep out of children's reach, with temperature guidance for storage. The original manufacturer is Lupin Pharma, Baltimore, MD.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.